{
     "PMID": "28759231",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170926",
     "LR": "20170926",
     "IS": "1520-4804 (Electronic) 0022-2623 (Linking)",
     "VI": "60",
     "IP": "16",
     "DP": "2017 Aug 24",
     "TI": "Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer's Disease: 2-(3-Phenyl-1H-pyrazol-1-yl)-nicotinamides.",
     "PG": "7123-7138",
     "LID": "10.1021/acs.jmedchem.7b00731 [doi]",
     "AB": "Calpain overactivation has been implicated in a variety of pathological disorders including ischemia/reperfusion injury, cataract formation, and neurodegenerative diseases such as Alzheimer's disease (AD). Herein we describe our efforts leading to the identification of ketoamide-based 2-(3-phenyl-1H-pyrazol-1-yl)nicotinamides as potent and reversible inhibitors of calpain with high selectivity versus related cysteine protease cathepsins, other proteases, and receptors. Broad efficacy in a set of preclinical models relevant to AD suggests that inhibition of calpain represents an attractive approach with potential benefit for the treatment of AD.",
     "FAU": [
          "Kling, Andreas",
          "Jantos, Katja",
          "Mack, Helmut",
          "Hornberger, Wilfried",
          "Drescher, Karla",
          "Nimmrich, Volker",
          "Relo, Ana",
          "Wicke, Karsten",
          "Hutchins, Charles W",
          "Lao, Yanbin",
          "Marsh, Kennan",
          "Moeller, Achim"
     ],
     "AU": [
          "Kling A",
          "Jantos K",
          "Mack H",
          "Hornberger W",
          "Drescher K",
          "Nimmrich V",
          "Relo A",
          "Wicke K",
          "Hutchins CW",
          "Lao Y",
          "Marsh K",
          "Moeller A"
     ],
     "AUID": [
          "ORCID: http://orcid.org/0000-0002-9959-6697"
     ],
     "AD": "Neuroscience Research, AbbVie Deutschland GmbH & Co. KG , Knollstrasse, 67061 Ludwigshafen, Germany. Neuroscience Research, AbbVie Deutschland GmbH & Co. KG , Knollstrasse, 67061 Ludwigshafen, Germany. Neuroscience Research, AbbVie Deutschland GmbH & Co. KG , Knollstrasse, 67061 Ludwigshafen, Germany. Neuroscience Research, AbbVie Deutschland GmbH & Co. KG , Knollstrasse, 67061 Ludwigshafen, Germany. Neuroscience Research, AbbVie Deutschland GmbH & Co. KG , Knollstrasse, 67061 Ludwigshafen, Germany. Neuroscience Research, AbbVie Deutschland GmbH & Co. KG , Knollstrasse, 67061 Ludwigshafen, Germany. Neuroscience Research, AbbVie Deutschland GmbH & Co. KG , Knollstrasse, 67061 Ludwigshafen, Germany. Neuroscience Research, AbbVie Deutschland GmbH & Co. KG , Knollstrasse, 67061 Ludwigshafen, Germany. AbbVie Inc. , 1 North Waukegan Road, North Chicago, Illinois 60064-6125, United States. AbbVie Inc. , 1 North Waukegan Road, North Chicago, Illinois 60064-6125, United States. AbbVie Inc. , 1 North Waukegan Road, North Chicago, Illinois 60064-6125, United States. Neuroscience Research, AbbVie Deutschland GmbH & Co. KG , Knollstrasse, 67061 Ludwigshafen, Germany.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20170815",
     "PL": "United States",
     "TA": "J Med Chem",
     "JT": "Journal of medicinal chemistry",
     "JID": "9716531",
     "RN": [
          "0 (A-933548)",
          "0 (Aminobutyrates)",
          "0 (Cysteine Proteinase Inhibitors)",
          "0 (Pyrazoles)",
          "12634-43-4 (Spectrin)",
          "25X51I8RD4 (Niacinamide)",
          "EC 3.4.- (Cathepsins)",
          "EC 3.4.22.- (Calpain)",
          "EC 3.4.22.52 (CAPN1 protein, human)"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/*drug therapy",
          "Aminobutyrates/chemical synthesis/pharmacokinetics/*pharmacology",
          "Animals",
          "Calpain/*antagonists & inhibitors",
          "Cathepsins",
          "Cysteine Proteinase Inhibitors/chemical synthesis/pharmacokinetics/*pharmacology",
          "Dogs",
          "Hippocampus/metabolism",
          "Humans",
          "Inhibitory Concentration 50",
          "Macaca fascicularis",
          "Male",
          "Microsomes, Liver/metabolism",
          "Niacinamide/*analogs & derivatives/chemical synthesis/pharmacokinetics/*pharmacology",
          "Pyrazoles/chemical synthesis/pharmacokinetics/*pharmacology",
          "Rats, Inbred F344",
          "Rats, Sprague-Dawley",
          "Rats, Wistar",
          "Sleep, REM/drug effects",
          "Spectrin/metabolism",
          "Stereoisomerism",
          "Structure-Activity Relationship"
     ],
     "EDAT": "2017/08/02 06:00",
     "MHDA": "2017/09/28 06:00",
     "CRDT": [
          "2017/08/01 06:00"
     ],
     "PHST": [
          "2017/08/02 06:00 [pubmed]",
          "2017/09/28 06:00 [medline]",
          "2017/08/01 06:00 [entrez]"
     ],
     "AID": [
          "10.1021/acs.jmedchem.7b00731 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Med Chem. 2017 Aug 24;60(16):7123-7138. doi: 10.1021/acs.jmedchem.7b00731. Epub 2017 Aug 15.",
     "term": "hippocampus"
}